Structure

Physi-Chem Properties

Molecular Weight:  484.16
Volume:  447.143
LogP:  -0.225
LogD:  0.085
LogS:  -1.989
# Rotatable Bonds:  7
TPSA:  195.6
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.219
Synthetic Accessibility Score:  4.828
Fsp3:  0.591
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.422
MDCK Permeability:  9.415452223038301e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.826
Human Intestinal Absorption (HIA):  0.794
20% Bioavailability (F20%):  0.107
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.282
Plasma Protein Binding (PPB):  32.822105407714844%
Volume Distribution (VD):  0.34
Pgp-substrate:  41.43641662597656%

ADMET: Metabolism

CYP1A2-inhibitor:  0.014
CYP1A2-substrate:  0.024
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.196
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.104
CYP3A4-inhibitor:  0.047
CYP3A4-substrate:  0.043

ADMET: Excretion

Clearance (CL):  1.364
Half-life (T1/2):  0.836

ADMET: Toxicity

hERG Blockers:  0.078
Human Hepatotoxicity (H-HT):  0.153
Drug-inuced Liver Injury (DILI):  0.679
AMES Toxicity:  0.031
Rat Oral Acute Toxicity:  0.051
Maximum Recommended Daily Dose:  0.012
Skin Sensitization:  0.041
Carcinogencity:  0.852
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.128

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478236

Natural Product ID:  NPC478236
Common Name*:   6-O-(4-hydroxybenzoyl)-5,7-bisdeoxycynanchoside
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  OTIAAGNDDJEMIJ-KAPCZBBJSA-N
Standard InCHI:  InChI=1S/C22H28O12/c23-8-14-16(26)17(27)18(28)21(33-14)34-20-15-12(5-6-31-20)13(7-22(15,30)9-24)32-19(29)10-1-3-11(25)4-2-10/h1-6,12-18,20-21,23-28,30H,7-9H2/t12-,13+,14?,15+,16?,17?,18-,20-,21-,22+/m0/s1
SMILES:  [H][C@]12[C@H](O[C@@H]3OC(CO)C(O)C(O)[C@@H]3O)OC=C[C@@]1([H])[C@H](OC(=O)C1=CC=C(O)C=C1)C[C@@]2(O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota stem bark Medicinal Plant Garden, College of Pharmacy, Ewha Womans University 2013-DEC PMID[28787158]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[9599262]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478236 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9859 High Similarity NPC478234
0.9792 High Similarity NPC194705
0.9722 High Similarity NPC158546
0.9722 High Similarity NPC289021
0.9521 High Similarity NPC478235
0.9507 High Similarity NPC77922
0.9507 High Similarity NPC473281
0.9456 High Similarity NPC229354
0.9392 High Similarity NPC478232
0.9384 High Similarity NPC240592
0.9384 High Similarity NPC117346
0.9338 High Similarity NPC138993
0.9216 High Similarity NPC476011
0.9184 High Similarity NPC96599
0.9178 High Similarity NPC473149
0.9103 High Similarity NPC296659
0.9103 High Similarity NPC202391
0.9085 High Similarity NPC474936
0.9038 High Similarity NPC130730
0.9038 High Similarity NPC301910
0.9032 High Similarity NPC109990
0.9028 High Similarity NPC46644
0.9021 High Similarity NPC49597
0.9013 High Similarity NPC475378
0.8973 High Similarity NPC184464
0.8973 High Similarity NPC251062
0.8968 High Similarity NPC206815
0.8968 High Similarity NPC145847
0.8954 High Similarity NPC187205
0.8933 High Similarity NPC474620
0.8933 High Similarity NPC475379
0.8926 High Similarity NPC161955
0.8912 High Similarity NPC475528
0.8904 High Similarity NPC186296
0.8904 High Similarity NPC478250
0.8897 High Similarity NPC137501
0.8897 High Similarity NPC7518
0.8897 High Similarity NPC159387
0.8897 High Similarity NPC154262
0.8889 High Similarity NPC31745
0.8889 High Similarity NPC220936
0.8851 High Similarity NPC474268
0.8851 High Similarity NPC119773
0.8851 High Similarity NPC475539
0.8851 High Similarity NPC143246
0.8824 High Similarity NPC475484
0.8805 High Similarity NPC21956
0.8803 High Similarity NPC114116
0.8797 High Similarity NPC282551
0.8776 High Similarity NPC237872
0.8776 High Similarity NPC88754
0.8776 High Similarity NPC302286
0.8776 High Similarity NPC263397
0.8776 High Similarity NPC116104
0.8774 High Similarity NPC179914
0.875 High Similarity NPC471345
0.8733 High Similarity NPC189631
0.8725 High Similarity NPC473867
0.8716 High Similarity NPC63304
0.8716 High Similarity NPC478240
0.8667 High Similarity NPC18789
0.8662 High Similarity NPC254819
0.8649 High Similarity NPC293154
0.8649 High Similarity NPC152796
0.8649 High Similarity NPC475213
0.8639 High Similarity NPC80098
0.8621 High Similarity NPC472132
0.86 High Similarity NPC37838
0.8599 High Similarity NPC208676
0.8599 High Similarity NPC130489
0.8591 High Similarity NPC194938
0.859 High Similarity NPC329997
0.858 High Similarity NPC470685
0.8571 High Similarity NPC257847
0.8562 High Similarity NPC269914
0.8562 High Similarity NPC478249
0.8542 High Similarity NPC322503
0.8542 High Similarity NPC470143
0.8497 Intermediate Similarity NPC147224
0.8497 Intermediate Similarity NPC35097
0.8487 Intermediate Similarity NPC120728
0.8487 Intermediate Similarity NPC308178
0.8483 Intermediate Similarity NPC169398
0.8477 Intermediate Similarity NPC291153
0.8477 Intermediate Similarity NPC473147
0.8471 Intermediate Similarity NPC49173
0.8452 Intermediate Similarity NPC229548
0.8452 Intermediate Similarity NPC478241
0.8452 Intermediate Similarity NPC89693
0.8403 Intermediate Similarity NPC475824
0.8387 Intermediate Similarity NPC203664
0.8385 Intermediate Similarity NPC180586
0.8377 Intermediate Similarity NPC182350
0.8377 Intermediate Similarity NPC69367
0.8355 Intermediate Similarity NPC212808
0.8354 Intermediate Similarity NPC475663
0.8354 Intermediate Similarity NPC4747
0.8354 Intermediate Similarity NPC226759
0.8354 Intermediate Similarity NPC104275
0.8354 Intermediate Similarity NPC286919
0.8344 Intermediate Similarity NPC172920
0.8344 Intermediate Similarity NPC156624
0.8333 Intermediate Similarity NPC65833
0.8323 Intermediate Similarity NPC140151
0.8313 Intermediate Similarity NPC117943
0.8313 Intermediate Similarity NPC293568
0.8313 Intermediate Similarity NPC477627
0.8312 Intermediate Similarity NPC92117
0.8311 Intermediate Similarity NPC170718
0.8311 Intermediate Similarity NPC469364
0.8311 Intermediate Similarity NPC101686
0.8311 Intermediate Similarity NPC65262
0.8303 Intermediate Similarity NPC195972
0.8302 Intermediate Similarity NPC469384
0.8289 Intermediate Similarity NPC108455
0.8289 Intermediate Similarity NPC210330
0.828 Intermediate Similarity NPC472127
0.828 Intermediate Similarity NPC194095
0.828 Intermediate Similarity NPC327032
0.828 Intermediate Similarity NPC472128
0.828 Intermediate Similarity NPC191046
0.8278 Intermediate Similarity NPC242756
0.8269 Intermediate Similarity NPC134905
0.8269 Intermediate Similarity NPC36130
0.8267 Intermediate Similarity NPC79908
0.8258 Intermediate Similarity NPC87630
0.8258 Intermediate Similarity NPC116292
0.8258 Intermediate Similarity NPC179128
0.8258 Intermediate Similarity NPC267469
0.8247 Intermediate Similarity NPC248257
0.8247 Intermediate Similarity NPC120621
0.8235 Intermediate Similarity NPC208293
0.8228 Intermediate Similarity NPC10205
0.8224 Intermediate Similarity NPC471028
0.8224 Intermediate Similarity NPC229036
0.8217 Intermediate Similarity NPC157898
0.8212 Intermediate Similarity NPC31081
0.8212 Intermediate Similarity NPC245219
0.8212 Intermediate Similarity NPC296643
0.8194 Intermediate Similarity NPC75945
0.8194 Intermediate Similarity NPC111785
0.8182 Intermediate Similarity NPC252114
0.8182 Intermediate Similarity NPC276047
0.8182 Intermediate Similarity NPC267733
0.8176 Intermediate Similarity NPC478248
0.8176 Intermediate Similarity NPC212729
0.8176 Intermediate Similarity NPC471405
0.8169 Intermediate Similarity NPC145287
0.816 Intermediate Similarity NPC265600
0.816 Intermediate Similarity NPC294722
0.8156 Intermediate Similarity NPC52097
0.8153 Intermediate Similarity NPC469456
0.8153 Intermediate Similarity NPC289438
0.8151 Intermediate Similarity NPC478255
0.8151 Intermediate Similarity NPC281798
0.8148 Intermediate Similarity NPC41009
0.8141 Intermediate Similarity NPC104172
0.8141 Intermediate Similarity NPC88886
0.8141 Intermediate Similarity NPC35160
0.8141 Intermediate Similarity NPC162569
0.8138 Intermediate Similarity NPC253595
0.8137 Intermediate Similarity NPC478265
0.8129 Intermediate Similarity NPC92054
0.8129 Intermediate Similarity NPC140722
0.8129 Intermediate Similarity NPC4958
0.8125 Intermediate Similarity NPC472860
0.8125 Intermediate Similarity NPC106677
0.8125 Intermediate Similarity NPC175333
0.8125 Intermediate Similarity NPC133984
0.8125 Intermediate Similarity NPC288416
0.8121 Intermediate Similarity NPC294470
0.8121 Intermediate Similarity NPC27721
0.8117 Intermediate Similarity NPC474044
0.8112 Intermediate Similarity NPC126991
0.8112 Intermediate Similarity NPC83218
0.811 Intermediate Similarity NPC469396
0.811 Intermediate Similarity NPC88176
0.811 Intermediate Similarity NPC149002
0.811 Intermediate Similarity NPC469458
0.811 Intermediate Similarity NPC469459
0.811 Intermediate Similarity NPC469419
0.8101 Intermediate Similarity NPC3746
0.8101 Intermediate Similarity NPC44260
0.8101 Intermediate Similarity NPC61152
0.8101 Intermediate Similarity NPC137813
0.8101 Intermediate Similarity NPC205037
0.8101 Intermediate Similarity NPC16024
0.8098 Intermediate Similarity NPC120012
0.8098 Intermediate Similarity NPC161151
0.8092 Intermediate Similarity NPC284957
0.8085 Intermediate Similarity NPC11724
0.8082 Intermediate Similarity NPC17567
0.8075 Intermediate Similarity NPC289811
0.8075 Intermediate Similarity NPC287872
0.8075 Intermediate Similarity NPC160780
0.8075 Intermediate Similarity NPC74319
0.8069 Intermediate Similarity NPC225307
0.8067 Intermediate Similarity NPC475195
0.8067 Intermediate Similarity NPC310252
0.8067 Intermediate Similarity NPC84789

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478236 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8758 High Similarity NPD7685 Pre-registration
0.8012 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD4628 Phase 3
0.7692 Intermediate Similarity NPD6190 Approved
0.7676 Intermediate Similarity NPD9545 Approved
0.7662 Intermediate Similarity NPD7266 Discontinued
0.764 Intermediate Similarity NPD4380 Phase 2
0.7633 Intermediate Similarity NPD3818 Discontinued
0.7568 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7054 Approved
0.7483 Intermediate Similarity NPD3764 Approved
0.7451 Intermediate Similarity NPD230 Phase 1
0.7442 Intermediate Similarity NPD7472 Approved
0.741 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD1653 Approved
0.7399 Intermediate Similarity NPD6797 Phase 2
0.7394 Intermediate Similarity NPD8455 Phase 2
0.7375 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD7075 Discontinued
0.7356 Intermediate Similarity NPD7251 Discontinued
0.7356 Intermediate Similarity NPD6559 Discontinued
0.7341 Intermediate Similarity NPD7074 Phase 3
0.7337 Intermediate Similarity NPD7199 Phase 2
0.7326 Intermediate Similarity NPD7799 Discontinued
0.7314 Intermediate Similarity NPD7808 Phase 3
0.729 Intermediate Similarity NPD6653 Approved
0.7278 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD8313 Approved
0.7273 Intermediate Similarity NPD8312 Approved
0.7256 Intermediate Similarity NPD7458 Discontinued
0.7239 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD6801 Discontinued
0.7215 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6002 Phase 3
0.7215 Intermediate Similarity NPD6004 Phase 3
0.7215 Intermediate Similarity NPD6005 Phase 3
0.7188 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6273 Approved
0.717 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5403 Approved
0.7126 Intermediate Similarity NPD7228 Approved
0.7126 Intermediate Similarity NPD37 Approved
0.7125 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD6234 Discontinued
0.7117 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD1091 Approved
0.7105 Intermediate Similarity NPD5647 Approved
0.7101 Intermediate Similarity NPD4967 Phase 2
0.7101 Intermediate Similarity NPD4966 Approved
0.7101 Intermediate Similarity NPD4965 Approved
0.7099 Intermediate Similarity NPD7236 Approved
0.7089 Intermediate Similarity NPD7033 Discontinued
0.7089 Intermediate Similarity NPD1510 Phase 2
0.7081 Intermediate Similarity NPD3750 Approved
0.7063 Intermediate Similarity NPD1549 Phase 2
0.7055 Intermediate Similarity NPD6799 Approved
0.7041 Intermediate Similarity NPD3817 Phase 2
0.7041 Intermediate Similarity NPD5402 Approved
0.7024 Intermediate Similarity NPD1934 Approved
0.7021 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD5401 Approved
0.7006 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6355 Discontinued
0.7 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.6989 Remote Similarity NPD5844 Phase 1
0.6988 Remote Similarity NPD7239 Suspended
0.6982 Remote Similarity NPD5761 Phase 2
0.6982 Remote Similarity NPD7819 Suspended
0.6982 Remote Similarity NPD5760 Phase 2
0.6982 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6964 Remote Similarity NPD7411 Suspended
0.6941 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6936 Remote Similarity NPD8127 Discontinued
0.6928 Remote Similarity NPD6362 Approved
0.6918 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6166 Phase 2
0.6914 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6909 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6909 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6905 Remote Similarity NPD6599 Discontinued
0.6905 Remote Similarity NPD7028 Phase 2
0.6895 Remote Similarity NPD7435 Discontinued
0.6888 Remote Similarity NPD7930 Approved
0.6882 Remote Similarity NPD2801 Approved
0.6882 Remote Similarity NPD1465 Phase 2
0.6879 Remote Similarity NPD6663 Approved
0.6879 Remote Similarity NPD6233 Phase 2
0.6872 Remote Similarity NPD6765 Approved
0.6872 Remote Similarity NPD6764 Approved
0.6868 Remote Similarity NPD8150 Discontinued
0.6868 Remote Similarity NPD8434 Phase 2
0.686 Remote Similarity NPD3749 Approved
0.6859 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6859 Remote Similarity NPD8319 Approved
0.6859 Remote Similarity NPD8320 Phase 1
0.6848 Remote Similarity NPD1511 Approved
0.6842 Remote Similarity NPD9269 Phase 2
0.6839 Remote Similarity NPD9494 Approved
0.6839 Remote Similarity NPD7585 Approved
0.6839 Remote Similarity NPD5736 Approved
0.6836 Remote Similarity NPD3751 Discontinued
0.6832 Remote Similarity NPD2935 Discontinued
0.6832 Remote Similarity NPD2796 Approved
0.6832 Remote Similarity NPD1551 Phase 2
0.6828 Remote Similarity NPD6534 Approved
0.6828 Remote Similarity NPD6535 Approved
0.6825 Remote Similarity NPD6782 Approved
0.6825 Remote Similarity NPD6777 Approved
0.6825 Remote Similarity NPD6781 Approved
0.6825 Remote Similarity NPD6780 Approved
0.6825 Remote Similarity NPD6778 Approved
0.6825 Remote Similarity NPD6779 Approved
0.6825 Remote Similarity NPD6776 Approved
0.6824 Remote Similarity NPD9493 Approved
0.6823 Remote Similarity NPD7999 Approved
0.6818 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6815 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7097 Phase 1
0.6807 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6807 Remote Similarity NPD2532 Approved
0.6807 Remote Similarity NPD2534 Approved
0.6807 Remote Similarity NPD2533 Approved
0.6806 Remote Similarity NPD7497 Discontinued
0.6802 Remote Similarity NPD3882 Suspended
0.68 Remote Similarity NPD6232 Discontinued
0.6793 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6792 Remote Similarity NPD1933 Approved
0.679 Remote Similarity NPD5763 Approved
0.679 Remote Similarity NPD5762 Approved
0.6788 Remote Similarity NPD7583 Approved
0.678 Remote Similarity NPD7473 Discontinued
0.6778 Remote Similarity NPD7240 Approved
0.6774 Remote Similarity NPD2798 Approved
0.677 Remote Similarity NPD3748 Approved
0.6768 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6766 Remote Similarity NPD1512 Approved
0.6753 Remote Similarity NPD1876 Approved
0.6746 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6744 Remote Similarity NPD5353 Approved
0.6732 Remote Similarity NPD1608 Approved
0.6731 Remote Similarity NPD2861 Phase 2
0.673 Remote Similarity NPD1240 Approved
0.6721 Remote Similarity NPD6784 Approved
0.6721 Remote Similarity NPD6785 Approved
0.672 Remote Similarity NPD7700 Phase 2
0.672 Remote Similarity NPD7699 Phase 2
0.6712 Remote Similarity NPD969 Suspended
0.671 Remote Similarity NPD2797 Approved
0.671 Remote Similarity NPD3094 Phase 2
0.671 Remote Similarity NPD1203 Approved
0.6709 Remote Similarity NPD3268 Approved
0.6709 Remote Similarity NPD6798 Discontinued
0.6707 Remote Similarity NPD1652 Phase 2
0.6705 Remote Similarity NPD3787 Discontinued
0.6705 Remote Similarity NPD7058 Phase 2
0.6705 Remote Similarity NPD7768 Phase 2
0.6705 Remote Similarity NPD7057 Phase 3
0.6704 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6701 Remote Similarity NPD7584 Approved
0.6689 Remote Similarity NPD9268 Approved
0.6687 Remote Similarity NPD5124 Phase 1
0.6687 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6686 Remote Similarity NPD5494 Approved
0.6684 Remote Similarity NPD7874 Approved
0.6684 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8166 Discontinued
0.6667 Remote Similarity NPD4308 Phase 3
0.6667 Remote Similarity NPD2799 Discontinued
0.665 Remote Similarity NPD7783 Phase 2
0.665 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6647 Remote Similarity NPD3455 Phase 2
0.6646 Remote Similarity NPD5958 Discontinued
0.6646 Remote Similarity NPD1607 Approved
0.6645 Remote Similarity NPD3225 Approved
0.6633 Remote Similarity NPD8151 Discontinued
0.6632 Remote Similarity NPD7698 Approved
0.6632 Remote Similarity NPD7697 Approved
0.6632 Remote Similarity NPD7696 Phase 3
0.6627 Remote Similarity NPD3887 Approved
0.6627 Remote Similarity NPD2354 Approved
0.6625 Remote Similarity NPD4140 Approved
0.6623 Remote Similarity NPD9717 Approved
0.6604 Remote Similarity NPD2313 Discontinued
0.6598 Remote Similarity NPD7870 Phase 2
0.6598 Remote Similarity NPD7871 Phase 2
0.6596 Remote Similarity NPD6212 Phase 3
0.6596 Remote Similarity NPD6213 Phase 3
0.6596 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6587 Remote Similarity NPD7440 Discontinued
0.6587 Remote Similarity NPD5058 Phase 3
0.6584 Remote Similarity NPD447 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data